In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taiwan Clears First Trial Of Stem Cell Technology

This article was originally published in PharmAsia News

Executive Summary

Taiwan's government has given its approval for local biotech Bionet to conduct the first clinical test of mesenchymal stem cell transplants in the country. That trial is the first of six trials Bionet plans, all under the sponsorship of the government. The first trial is to see if mesenchymal cells assist transplanted umbilical blood stem cells in treating leukemia and other diseases caused by hematopoietic stem cells that do not work correctly. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069537

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel